Aflofarm has expanded its product portfolio with Actimodan - the only registered medication on the Polish market containing the active substance modafinil, indicated for narcolepsy. From October, the medicine can be ordered through the portal and collected in one of 1,800 pharmacies throughout Poland.  

Actimodan is indicated to treat excessive sleepiness (difficulty in staying awake and an increased risk of falling asleep in inappropriate situations) associated with narcolepsy with or without cataplexy (loss of muscle tone) in adults.

Actimodan (Rx) contains the active substance of modafinil. Modafinil can be taken by adult narcolepsy patients to maintain wakefulness. Taking modafinil can improve narcolepsy and reduce the likelihood of sudden sleep onset episodes. Actimodan - is currently the only registered and available brand of modafinil in Poland.

Actimodan is available in packs of 30 or 100 tablets. The medication contains less than 1 mmol (23 mg) sodium per tablet, i.e. it is essentially 'sodium-free'.

The recommended dose is 200 mg daily. This dose can be taken once a day or in two divided doses (100 mg in the morning and 100 mg at noon). The tablets can be divided into two equal doses according to the score line. Doses up to 400 mg in one or two divided doses may be used in patients who do not respond adequately to the starting dose of 200 mg of modafinil.

You are kindly invited to watch videos from the scientific symposium: EXCESSIVE SLEEPINESS - CHALLENGES IN CLINICAL PRACTICE. MODAFINIL, A NEW THERAPEUTIC OPTION, which took place on September 21, 2021, and was focused on the problem of excessive sleepiness. You can find the link to the conference here:

The symposium was attended by members and the board of the Polish Sleep Research Society, staff of sleep medicine centers and sleep research employees, along with about 400 doctors who joined online.
The following issues were discussed during the meeting:

Narcolepsy - how to recognize and effectively treat?
Marcin Żarowski MD, PhD hab., Department and Clinic of Developmental Age Neurology, Medical University of Karol Marcinkowski in Poznań

Excessive sleepiness in mental disorders - methods of assessment and treatment
Daria Smułek PhD, Wacław Dyrda PhD, III Psychiatric Clinic and Sleep Medicine Center, Institute of Psychiatry and Neurology in Warsaw

Why Modafinil?
Professor Adam Wichniak MD, PhD hab., III Psychiatric Clinic and Sleep Medicine Center, Institute of Psychiatry and Neurology in Warsaw

Excessive sleepiness in obstructive sleep apnea (syndrome)
Małgorzata Czajkowska-Malinowska, MD, Kujawsko-Pomorskie Pulmonology Center in Bydgoszcz

Selected key elements of modern diagnosis and treatment of obstructive sleep apnea Szczepan Cofta, MD, PhD hab. Department and Clinic of Pulmonology, Medical University of Poznań